Loading...
Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling is critically required for CRPC. A new generation of medications targeting AR, such as abiraterone and enzalutamid...
Saved in:
| Published in: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483886/ https://ncbi.nlm.nih.gov/pubmed/28604629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers9060067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|